New article: Phase 1 clinical trial of the PI3Kδ inhibitor YY-20394 in patients with B-cell hematological malignancies https://t.co/xyV6JPr9Pk #FL #lymsm #hematology https://t.co/SCvH7kdLFb
925 followers
2,454 followers
Phase 1 clinical trial of the PI3Kδ inhibitor YY-20394 in patients with B-cell hematological malignancies #lymphoma #lymsm https://t.co/WT4KrKrsKD
925 followers
New article: Phase 1 clinical trial of the PI3Kδ inhibitor YY-20394 in patients with B-cell hematological malignancies https://t.co/f2SQYCIB5h #CLL #leusm #hematology
2,454 followers
Phase 1 clinical trial of the PI3Kδ inhibitor YY-20394 in patients with B-cell hematological malignancies #lymphoma #lymsm https://t.co/b0Tcm6OoCI